Brandywine Realty Trust

Brandywine Realty Trust (BDN) Market Cap

Brandywine Realty Trust has a market capitalization of .

No quote data available.

CEO: Gerard H. Sweeney

Sector: Real Estate

Industry: REIT - Office

IPO Date: 1986-07-24

Website: https://www.brandywinerealty.com

Brandywine Realty Trust (BDN) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia, Austin and Washington, D.C. markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 175 properties and 24.7 million square feet as of December 31, 2020 which excludes assets held for sale. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together.

Analyst Sentiment

33%
Underperform

From 5 Active Polls

1Y Forecast: $3.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$3

Median

$3

High Bound

$3

Average

$3

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$3.00
▼ -5.36% Upside
Low Target
$3.00
-5% Risk
Median Target
$3.00
-5% Mid
High Target
$3.00
-5% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 BRANDYWINE REALTY TRUST REIT (BDN) — Investment Overview

🧩 Business Model Overview

Brandywine Realty Trust operates as a diversified real estate owner focused on leasing and managing office and life-science oriented properties across select Mid-Atlantic markets, with an emphasis on Philadelphia and surrounding growth corridors. The value chain is straightforward: the company acquires and develops/renovates buildings, leases space to corporate tenants, and converts tenant demand into recurring cash flow through base rents plus tenant recoveries. Over time, property-level redevelopment (including repositioning older assets into modern office/life-science use cases) aims to preserve tenant relevance, support renewal activity, and improve average rent potential.

💰 Revenue Streams & Monetisation Model

  • Core recurring rental revenue: contractual lease payments from office and life-science space, typically supported by lease structures that include rent escalators over time.
  • Tenant recoveries and reimbursements: pass-throughs for operating expenses (e.g., property taxes, common-area maintenance), which can partially protect operating margins against cost inflation.
  • Ancillary income: parking and other property services that add incremental, often lower-volatility revenue tied to occupancy and tenant presence.
  • Repositioning and development economics: gains are pursued through higher-quality space delivery, improved lease terms, and potential value creation from redevelopment and leasing spreads over the cycle.

Margin drivers primarily include occupancy/lease-up efficiency, lease spreads versus market, recoverability of operating costs, and capital discipline (redevelopment intensity versus expected rental yield). In REITs such as BDN, the monetisation model is ultimately cash-flow conversion through stable leasing and cost control, supported by the REIT’s ability to finance and execute property upgrades.

🧠 Competitive Advantages & Market Positioning

BDN’s moat is best characterized as location-and-asset stickiness with property-level switching costs, reinforced by redevelopment capabilities in specific demand pockets.

  • Switching costs (tenant-level): office and life-science tenants face meaningful relocation frictions—buildout costs, technology infrastructure alignment, workforce considerations, and disruption risk. BDN can capture lease renewals and incremental demand when buildings remain operationally “ready” for tenant requirements (layout, systems, and amenity support).
  • Geographic concentration with submarket expertise: BDN focuses on Mid-Atlantic markets where demand can be more idiosyncratic than in mega-metro coastal markets. Concentration can improve leasing execution and operational focus versus competitors stretched across less coherent portfolios.
  • Redevelopment as an economic barrier: upgrading older assets into modern office/life-science-ready product creates a practical barrier to quick imitation because competitors must either (a) buy comparable buildings at scale or (b) fund similar capex programs—both time-consuming and capital-intensive.

COMPETITIVE BENCHMARKING

  • SL Green Realty (SLG) / Vornado Realty (VNO): more concentrated exposure to New York City core office demand and submarket dynamics. Their competitive center of gravity differs from BDN’s Mid-Atlantic footprint.
  • Alexandria Real Estate (ARE): deeper specialization in life science-enabled space, supported by a national platform approach. BDN competes in life-science adjacent demand through repositioning and tenant services, but with a more regionally concentrated portfolio.
  • Office REIT peers with broader regional spreads: these players may compete for tenants on amenities, lease incentives, and capital availability, while BDN’s differentiation tends to rest on property execution in its core markets rather than on scale across every major metro.

🚀 Multi-Year Growth Drivers

  • Life-science and modern workplace repositioning: structural tenant preference for higher-quality building systems, flexible layouts, and amenity-enabled environments supports incremental leasing value when assets are upgraded to match demand requirements.
  • Supply management in key submarkets: in markets where new competitive deliveries are limited or slow to complete, refurbished space can capture disproportionate leasing activity relative to older, non-upgraded stock.
  • Operating leverage from improved occupancy and expense management: as occupancy rises and lease-up stabilizes, fixed operating costs and leasing/marketing spend can create better per-space economics.
  • Rent resilience from lease structure design: lease contractual terms and recovery frameworks influence cash-flow durability through the cycle.

Over a 5–10 year horizon, the total addressable market is driven less by broad office growth and more by the share shift toward upgraded space, including life-science oriented facilities and workplace requirements that favor modernized assets. BDN’s growth math depends on maintaining competitive positioning within those narrower demand pockets and executing redevelopment without impairing balance-sheet flexibility.

⚠ Risk Factors to Monitor

  • Capital intensity and execution risk: repositioning requires timely capex and high-quality delivery; underperformance can compress returns and extend lease-up timelines.
  • Office demand cyclicality and tenant credit risk: leasing velocity, renewals, and concessions can deteriorate quickly when macro conditions weaken; tenant defaults can raise vacancy and cash-flow uncertainty.
  • Financing and interest rate sensitivity: REIT returns are affected by refinancing conditions, debt maturities, and the cost of capital; balance-sheet stress can force asset sales or restrictive capital allocation.
  • Concentration risk: Mid-Atlantic focus concentrates exposure to specific local market drivers (employment growth, development pipelines, and tenant consolidation decisions).
  • Regulatory and environmental liabilities: property taxes, permitting, and environmental compliance can affect redevelopment timing and operating costs.

📊 Valuation & Market View

In the REIT sector, equity valuation typically reflects cash-flow durability and net asset value-like assessments, with investors focusing on metrics such as FFO/AFFO, property-level income quality, debt maturity ladders, and implied capitalization rates. Multiple compression or expansion is generally driven by:

  • Interest rate expectations and credit conditions (discount rates and refinancing spreads).
  • Occupancy and lease-up trajectories (cash-flow confidence).
  • Redevelopment outcomes (ability to translate capex into sustainable rent and occupancy).
  • Balance-sheet risk (leverage, liquidity, and debt maturity profile).

For BDN, the market view often hinges on whether redevelopment and leasing strategies can sustain a competitive cost-of-space proposition and protect long-term cash-flow generation in its operating footprint.

🔍 Investment Takeaway

BDN’s long-term case rests on tenant-level switching costs created by relocation frictions, supported by redevelopment-driven differentiation in select Mid-Atlantic demand pockets. The investment outlook is most compelling when the company demonstrates disciplined execution—delivering upgraded space that preserves leasing momentum and supports AFFO durability—while maintaining balance-sheet flexibility through credit cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"BDN reported a quarterly revenue of $127 million, showing a 5% QoQ increase from $120.95 million and a 4.5% YoY growth from $121.52 million. Net income remains negative, down to -$48.9 million from -$37.04 million QoQ and significantly lower YoY from -$26.98 million. This reflects a notable operating struggle as EPS contracted from -$0.21 to -$0.28 QoQ. BDN's dividend yield is approximately 3%; however, it's important to note the payout ratio remains negative due to persistent losses. The company's total assets have remained stable QoQ, reflecting a modest asset increment but a decrease in equity from $999 million to $739 million YoY raises concerns. In terms of shareholder returns, the stock has decreased by 20.43% over the past year, further depressing the overall attractiveness. Despite regular dividends, the negative earnings trend and steep share price decline reduce total return prospects. Market consensus targets the stock at $4, which suggests potential upsides from the current $2.96 price, but substantial strategic pivots would be essential for realized gains."

Revenue Growth

Fair

Revenue grew YoY by 4.5% and QoQ by 5%, indicating a positive trajectory amidst ongoing challenges.

Profitability

Neutral

Margins are contracting, with ongoing negative earnings and deteriorating EPS over both periods.

Cash Flow Quality

Neutral

Negative net income with regular dividends, but questionable dividend sustainability given ongoing losses.

Leverage & Balance Sheet

Caution

Stability in total assets, but declining equity levels and ongoing negative net debt.

Shareholder Returns

Neutral

Dividend continues, but a 20.43% decrease in share price limits total return attractiveness.

Analyst Sentiment & Valuation

Caution

Current price is below median target, suggesting potential upside; however, sentiment hinges on operational recovery.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

BDN’s Q1 2026 results were on-plan for core cash earnings (FFO $0.11/share, in line) but GAAP was dragged by ~$11.9 million of non-cash impairment charges. Operating momentum is evidenced by strong occupancy/leasing in Philadelphia (94% occupied / 96% leased) and leasing activity of 422,000 sq ft, including the highest wholly owned leasing since 2024. The company is actively converting tours (53% to proposal; 37% to executed leases) and running ahead on speculative revenue (94% of the $400k target). Management reiterated unchanged full-year metrics while narrowing the FFO range around a $0.55 midpoint and maintaining guidance despite mark-to-market declines. The central credit catalyst remains portfolio recycling: ~$305 million under agreement with most closings expected in Q2, supporting deleveraging toward investment-grade metrics (net debt/EBITDA targeted ~8.04x–8.08x). Key headwinds include Austin’s leasing drag (340 bps) and life science timing/regulatory risk, though 3151 now shows improved “green shoots.”

AI IconGrowth Catalysts

  • Spec revenue momentum: achieved 94% of $400,000 speculative revenue target at midpoint of 2026 guidance, running ahead of last year
  • Philadelphia operating strength: 94% occupied / 96% leased in Philadelphia CBD & University City; only 6% rolling through year-end 2028
  • Leasing conversion improvement: 53% of tours converted to proposal; 37% converted from proposal to executed lease (trailing four quarters)
  • Renewed life science/office pivot for 3151: pipeline includes larger institutions with slow execution and smaller life science companies; visible near-term revenue as leases execute
  • One Uptown upside: six proposals outstanding totaling just shy of 100,000 sq ft; existing building pipeline acceleration plus planned redevelopment of Building 902 in 2027
  • Solaris recapitalization optionality: renewal season showing a ~16% uptick in renewals (supports 2026 recap timing/value)

Business Development

  • ATX joint ventures: plan to recapitalize both projects on a pari passu common equity basis during 2026 (owner minority stake) or via outright sale
  • Schuylkill Yards: preferred partner buyout temporarily raised leverage (management cites this as a key factor to normalize credit metrics)
  • 3151 Market Street: acquired partner’s interest in 2025; management highlights development producing operating losses and the pipeline building to ~1.2 million sq ft (50% office / 50% life science)
  • One Uptown: institutional interest to partner on recap; pipeline plus planned Building 902 redevelopment tied to tenant demand

AI IconFinancial Highlights

  • Net loss: $48.9 million, or $0.28/share; driven by one-time non-cash property impairments of ~$11.9 million, or $0.07/share
  • FFO: $20 million, or $0.11/share—in line with consensus and management guidance
  • Q1 operating/NOI: property-level NOI $70.2 million, $0.8 million above reforecast due to better portfolio margins
  • GAAP mark-to-market: 4.1%; cash mark-to-market: -2.6% (both below annual business ranges); management expects improvement in the next three quarters while maintaining full-year guidance range
  • Same-store: +0.8% GAAP and +3.3% cash basis—both above current guidance ranges
  • Leverage/coverage: Q1 interest coverage and debt service both 1.7x; annualized combined net debt/EBITDA 9.18x and core 8.18x; decreases expected during the rest of the year with sales and debt reduction
  • Second quarter guidance (core items): property-level operating income ~$72.3 million (+$1.3 million sequential) with offsets from Radnor Hotel start-up costs; FFO contribution from joint ventures expected at -$0.9 million (higher floating-rate interest expense)

AI IconCapital Funding

  • Liquidity at quarter end: $36 million cash; $65 million outstanding on unsecured line of credit
  • Share repurchase capacity: ~$82 million available under existing program; management frames buybacks as earnings-neutral/leverage-neutral contingent on credit metric progress
  • Secured financing plan: repay 3025 JFK construction loan in Q2; refinance with ~7-year ~$100 million financing at an all-in rate in the mid-5% range
  • Debt recap: 3025 JFK consolidated construction loan ~$178 million matures July 2026; secured residential portion financed ~$100 million; proceeds and line borrowings used to unencumber the office portion
  • ATX recapitalizations: expected cash generation of $40 million to $50 million used to reduce wholly owned leverage (slightly accretive to earnings; benefits not included in FFO guidance due to later-in-2026 ownership/timing)
  • Full-year CAD: Q1 CAD payout 92.7%; management expects full-year payout ratio to remain within a 70% to 90% range as FFO improves
  • Rest-of-year capital plan: ~$450 million active capital; management expects ~ $10 million of net outstanding on the line of credit after uses/sources
  • Expected leverage/capability metrics for balance of year: net debt/EBITDA within 8.04x–8.08x; fixed charge coverage ~1.8x–2.0x (assuming sales + ATX recap execution)

AI IconStrategy & Ops

  • Portfolio recycling: ~$305 million of potential sales under agreement/in due diligence; majority expected to close in Q2; management cites pricing in line with guidance
  • Sales program mix testing: management broadened asset types to test investor appetite and drive sales velocity and pricing targets
  • Capital ratio: below targeted 6.4% due to a low-/no-capital deal in one portfolio; guidance range maintained
  • Pre-leasing/absorption expectations: positive net absorption expected for first time in several years; forward leasing after year-end totaled 182,000 sq ft
  • Operational automation/IT: none disclosed in the transcript
  • Market monitoring for office-to-residential conversion: monitoring >5 million sq ft (~11% of CBD office inventory), consisting of 1.2 million recently converted, 1.3 million in active redevelopment, and 2.5 million announced/planning

AI IconMarket Outlook

  • 2026 metrics guidance: management states full-year operating/financial metrics remain unchanged from original plan; FFO midpoint maintained at $0.55 while narrowing the range
  • Q2 guidance: property-level operating income ~$72.3 million; G&A ~$9.5 million; interest expense ~$43 million including ~$7.1 million capitalized interest; diluted share count ~180 million (no impact yet from potential sales/buybacks)
  • Leasing pipeline: operating portfolio leasing pipeline up ~200,000 sq ft from last quarter to 1.7 million sq ft, with ~314,000 sq ft in advanced negotiations; notes exclusion of leasing pipelines at 3151 and One Uptown

AI IconRisks & Headwinds

  • Austin underperformance: Austin occupancy at 70% lagging rest of portfolio, creating a 340-basis-point drop in overall company leasing levels
  • Life science leasing timing risk: pipeline execution pace described as challenging; regulatory risk macro overhang remains (management cites regulatory risk overhang in life science)
  • Development losses pressure leverage metrics: elevated until increased revenue comes online, particularly 3151 which is currently a $250 million wholly owned investment producing operating losses
  • Joint venture near-term drag: Q2 JV FFO contribution expected negative (-$0.9 million) due to higher interest rates on floating-rate debt
  • Mark-to-market volatility: cash mark-to-market decreased -2.6% (below annual business ranges) though management expects improvement

Q&A: Analyst Interest

  • Sales and additional dispositions: Management explained buyer interest informs sales velocity beyond current contracts by testing a broad product range in the market. They emphasized competitive bid processes and planned to add other properties based on investor sentiment, supported by improving debt-market underwriting confidence and 60–90 day closings.
  • One Uptown / Building 902 demand composition: Management described demand as primarily in-market prospects with some expansion needs, plus renovations targeted after zoning-capacity uptick and a large tenant’s pending departure. For 900-building renovations, they cited mostly in-market prospects, sometimes with consolidation/expansion, and accelerated planning for rapid renovation execution.
  • Life science leasing trajectory at 3151: Management said they see “green shoots” with improving capital flow and constructive tenant conversation tone, while acknowledging regulatory risk macro overhang. They highlighted a pipeline of larger institutions with slow execution, smaller life science firms in active dialogue, and an office-to-life-science pivot from tight Class A supply.

Sentiment: MIXED

Note: This summary was synthesized by AI from the BDN Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Brandywine Realty Trust (BDN) Financial Profile